Financials
- Market Capitalization 480.69 M
- Employee 40
- Founded 2022
- CEO N/A
- Website www.zurabio.com
- Headquarter Cayman Islands
- FIGI UNKNOWN
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.94
ratio cours/chiffre d'affaires
100.37
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2946 | KYTX Kyverna Therapeutics, Inc. - Common Stock | 7.94 USD | +2.19% | -16.77% | -2.58% | +103.59% | 482.71 M USD | ||
| 2948 | STTK Shattuck Labs, Inc. - Common Stock | 6.29 USD | -2.18% | -13.24% | +34.69% | +706.41% | 482.32 M USD | ||
| 2953 | SGMT Sagimet Biosciences Inc. - Series A Common Stock | 7.76 USD | +8.53% | +0.91% | +22.59% | -19.17% | 479.19 M USD | ||
| 2965 | PROK ProKidney Corp. - Class A Ordinary Shares | 1.55 USD | -3.73% | -20.10% | -6.63% | -25.48% | 468.19 M USD |